DS28120313 is primarily explored for its potential in therapeutic applications, particularly in the field of oncology. It is being studied for its ability to inhibit specific pathways involved in cancer cell proliferation and survival. Researchers are investigating its efficacy in targeting certain types of tumors, with a focus on its role in inducing apoptosis and reducing tumor growth. Additionally, DS28120313 is being evaluated for its potential to enhance the effectiveness of existing cancer treatments when used in combination therapies. Its application extends to preclinical studies aimed at understanding its mechanism of action and optimizing its use in clinical settings.